We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.00
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 23.00
High: 23.00
Low: 23.00
Prev. Close: 23.00
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Contingent Consideration Shares & TVR

18 Apr 2024 10:00

RNS Number : 1721L
Mission Group PLC (The)
18 April 2024
 

18 April 2024

The Mission Group plc

("MISSION" the "Company" or the "Group")

 

Issue of Contingent Consideration Shares, Total Voting Rights

 

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, provides an update on contingent consideration payments in relation to certain of the Group's past acquisitions, Influence Sports & Media ("Influence") and Mezzo Labs Ltd ("Mezzo"), first announced on 8 December 2022 and 14 February 2023 respectively, and more recently referenced in the Group's final results for the year ended 31 December 2023 on 28 March 2024.

 

Under the terms of both acquisitions, deferred consideration contingent on the financial performance of the ongoing businesses is now payable in respect of the first financial year following completion of the acquisitions (the "Contingent Consideration"). The Contingent Consideration is to be satisfied by a combination of cash and Mission shares which has been agreed between the Company and the vendors in accordance with the provisions of the underlying acquisition agreements. As such, the Company will be issuing 2,222,222 ordinary shares in aggregate to the vendors of Influence and Mezzo at the vendors' request, comprising (i) 1,000,000 existing ordinary shares held by the Company's employee benefit trust and (ii) 1,222,222 new ordinary shares in the Company to be issued at a price of 22.5 pence per share based on the Company's average share price over the 10 business days preceding 17 April 2024 (the "New Ordinary Shares").

 

Application has therefore been made for 1,222,222 New Ordinary Shares to be issued to be admitted to trading on AIM with admission expected to take place on 23 April 2024 ("Admission").

 

Following the allotment and issue of the New Ordinary Shares, there will be 92,238,119 ordinary shares in issue. The Company holds no ordinary shares in treasury and therefore this figure may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

ENDS

 

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

Via Houston

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

MISSION is a collective of digital marketing and communications Agencies employing over 1,100 people across 25 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFISAAELSELL
Date   Source Headline
18th Apr 202410:00 amRNSIssue of Contingent Consideration Shares & TVR
2nd Apr 20247:00 amRNSFinal Results
28th Mar 20245:30 pmRNSFinal Results
17th Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDISPOSAL UPDATE - PATHFINDR
20th Dec 20237:34 amRNSTrading Statement
24th Nov 202312:46 pmRNSBoard Change
7th Nov 20232:47 pmRNSNotification of Major Holdings
31st Oct 20235:07 pmRNSHolding(s) in Company
31st Oct 20239:29 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSTRADING UPDATE AND REVISED OUTLOOK FOR 2023
19th Oct 20236:25 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2023
25th Sep 202310:27 amRNSNEW CONTRACT WIN
20th Sep 20239:44 amRNSInvestor Presentation
27th Jul 20237:01 amRNSTrading Update
27th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:44 pmRNSResult of AGM
20th Jun 20237:00 amRNSDirector Dealing
3rd Apr 20237:00 amRNSDividend Declaration
28th Mar 20237:00 amRNSFinal Results
24th Mar 20237:00 amRNSInvestor Presentation
16th Mar 202310:16 amRNSLaunch Of New Integrated Growth Media Agency
14th Feb 20237:00 amRNSACQUISITION OF MEZZO LABS
12th Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSACQUISITION OF INFLUENCE SPORTS & MEDIA
31st Oct 20224:39 pmRNSHolding(s) in Company
27th Sep 20227:01 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2022
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.